Alexion Reports Third Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall St rises on cooler inflation data, big bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Alexion Pharma (ALXN) Tops Q3 EPS by 66c, Updates FY Guidance
October 29, 2020 6:33 AM EDTAlexion Pharma (NASDAQ: ALXN) reported Q3 EPS of $3.24, $0.66 better than the analyst estimate of $2.58. Revenue for the quarter came in at $1.59 billion versus the consensus estimate of $1.42 billion.
GUIDANCE:
Alexion Pharma sees FY2020 EPS of $11.70-$12.00, versus the consensus of... More
